Martin Shkreli livestreamed himself violating lifetime pharma ban, FTC says

What happened: The FTC and seven state attorneys general asked a federal judge to hold Martin Shkreli in contempt, saying he violated his lifetime pharmaceutical industry ban by trading drug company stocks and discussing the industry on livestreams. Key numbers: Price raised from $17.50 to $750 per pill, over 4,000 percent. Seven-year prison sentence. Lifetime ban since 2022. Seven states joined. Why it matters: The filing alleges Shkreli violated the ban nearly the entire time it has been in effect, and the states involved are the same ones that sued him in 2020 over the Daraprim scheme. Coverage: 5 outlets in 24h

The FTC and seven state attorneys general asked a federal judge to hold Martin Shkreli in contempt, saying he violated his lifetime pharmaceutical industry ban by trading drug company stocks and discussing the industry on livestreams.

The filing alleges Shkreli violated the ban nearly the entire time it has been in effect, and the states involved are the same ones that sued him in 2020 over the Daraprim scheme.